Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Ruth Gruhn. (2023) An Anthropological Conception of the Initial Peopling of the Americas. PaleoAmerica 9:3, pages 167-173.
Read now
Read now
Brian J Gates, Trang T Nguyen, Stephen M Setter & Neal M Davies. (2005) Meloxicam: a reappraisal of pharmacokinetics, efficacy and safety. Expert Opinion on Pharmacotherapy 6:12, pages 2117-2140.
Read now
Read now
Roy Fleischmann, Imran Iqbal & Gleb Slobodin. (2002) Meloxicam. Expert Opinion on Pharmacotherapy 3:10, pages 1501-1512.
Read now
Read now
Shamsul Shah & Janet Hardy. (2001) A Review of the COX-2 Inhibitors. Progress in Palliative Care 9:2, pages 47-52.
Read now
Read now
Articles from other publishers (19)
Ashish Srivastava & Dr Sanjay K Pandey. (2022) Management of Myofascial Pain Syndrome: A Randomized Control Trial. Indian Journal of Physical Medicine and Rehabilitation 30:3, pages 81-84.
Crossref
Crossref
A. A. Golovacheva, V. A. Golovacheva & V. A. Parfenov. (2022) Kinesiotherapy and non-steroidal anti-inflammatory drugs for nonspecific lumbago. Neurology, Neuropsychiatry, Psychosomatics 14:1, pages 89-96.
Crossref
Crossref
V. A. Shirokov, A. V. Potaturko & N. L. Terekhov. (2020) Nonsteroidal anti-inflammatory drugs, muscle relaxants, and B-group vitamins in the treatment of lumbar ischialgia. Neurology, Neuropsychiatry, Psychosomatics 12:6, pages 71-76.
Crossref
Crossref
A. E. Karateev, A. M. Lila, N. V. Zagorodnii, V. N. Amirdzhanova, E. Lu. Pogozheva, E. S. Filatova & V. A. Nesterenko. (2020) Control of pain in the early post-traumatic period in the outpatient practice. Results of the multi-center observational study RAPTOR (Rational Analgesia PostTraumatic: an Observational Research). Terapevticheskii arkhiv 92:5, pages 69-77.
Crossref
Crossref
A. E. Karateev, A. M. Lila, E. Yu. Pogozheva, E. S. Filatova & V. N. Amirdzhanova. (2019) Factors influencing the efficacy of nonsteroidal anti-inflammatory drugs for acute low back pain. The results of the multicenter observational «CARAMBOL» (Clinical Analysis of Results of Analgesia by Meloxicam and its Safety in Acute Lumbodynia) study. Modern Rheumatology Journal 13:2, pages 31-37.
Crossref
Crossref
A. E. Karateev, A. M. Lila, E. Yu. Pogozheva, E. S. Filatova & V. N. Amirdzhanova. (2018) The efficacy of meloxicam in acute back pain: results of an observational non-interventional multicenter study. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:6, pages 24.
Crossref
Crossref
Mehul J. Desai, Vikramjeet Saini & Shawnjeet Saini. (2013) Myofascial Pain Syndrome: A Treatment Review. Pain and Therapy 2:1, pages 21-36.
Crossref
Crossref
Alberto L. Cione, Eduardo P. Tonni & Leopoldo Soibelzon. 2009. American Megafaunal Extinctions at the End of the Pleistocene. American Megafaunal Extinctions at the End of the Pleistocene
125
144
.
Tien-Tsai Cheng, Han-Ming Lai, Chun-Kai Chiu & Ying-Chou Chem. (2004) A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. Clinical Therapeutics 26:3, pages 399-406.
Crossref
Crossref
M NEKOOFAR, M SADEGHIPANAH & A DEHPOUR. (2003) Evaluation of Meloxicam (A Cox-2 Inhibitor) for Management of Postoperative Endodontic Pain: A Double-blind Placebo-controlled Study. Journal of Endodontics 29:10, pages 634-637.
Crossref
Crossref
Howard S. Smith & Whitney Baird. (2016) Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population. American Journal of Hospice and Palliative Medicine® 20:4, pages 297-306.
Crossref
Crossref
M. Del Tacca, R. Colucci, M. Fornai & C. Blandizzi. (2002) Efficacy and Tolerability of Meloxicam, a COX-2 Preferential Nonsteroidal Anti-Inflammatory Drug. Clinical Drug Investigation 22:12, pages 799-818.
Crossref
Crossref
Herman Hans WaldvogelHerman Hans Waldvogel. 2001. Analgetika Antinozizeptiva Adjuvanzien. Analgetika Antinozizeptiva Adjuvanzien
652
656
.
Herman Hans WaldvogelHerman Hans Waldvogel. 2001. Analgetika Antinozizeptiva Adjuvanzien. Analgetika Antinozizeptiva Adjuvanzien
421
521
.
Dennis J. CadaDanial E. BakerTerri Levien. (2017) Meloxicam. Hospital Pharmacy 35:8, pages 852-865.
Crossref
Crossref
Mark FeldmanAlexander T. McMahon. (2000) Do Cyclooxygenase-2 Inhibitors Provide Benefits Similar to Those of Traditional Nonsteroidal Anti-Inflammatory Drugs, with Less Gastrointestinal Toxicity?. Annals of Internal Medicine 132:2, pages 134.
Crossref
Crossref
Philip Schoenfeld. (1999) Gastrointestinal safety profile of meloxicam: a meta-analysis and systematic review of randomized controlled trials11The opinions and assertions contained herein are the sole views of the author and should not be construed to reflect the views of the Department of the Navy or the Department of Defense.. The American Journal of Medicine 107:6, pages 48-54.
Crossref
Crossref
Barbara Kaplan-Machlis & Barbara Storyk Klostermeyer. (2016) The Cyclooxygenase-2 Inhibitors: Safety and Effectiveness. Annals of Pharmacotherapy 33:9, pages 979-988.
Crossref
Crossref
Marelise Kruger & Karen McRae. (1999) PAIN MANAGEMENT IN CARDIOTHORACIC PRACTICE. Surgical Clinics of North America 79:2, pages 387-400.
Crossref
Crossref